Characteristics of emerging new autoimmune diseases after COVID-19 vaccination: a sub-study by the COVAD group (2024)
- Authors:
- Autor USP: SHINJO, SAMUEL KATSUYUKI - FM
- Unidade: FM
- DOI: 10.1111/1756-185X.15178
- Subjects: DOENÇAS AUTOIMUNES; VACINAS VIRAIS; VACINAÇÃO; COVID-19; MELATONINA
- Language: Inglês
- Imprenta:
- Source:
- Título: International journal of rheumatic diseases
- ISSN: 1756-1841
- Volume/Número/Paginação/Ano: v. 27, n. 5, article ID e15178, 11p, 2024
- Este artigo possui versão em acesso aberto
- URL de acesso aberto
- Versão do Documento: Versão publicada (Published version)
-
Status: Artigo aberto em periódico híbrido (Hybrid Open Access) -
ABNT
SHUMNALIEVA, Russka et al. Characteristics of emerging new autoimmune diseases after COVID-19 vaccination: a sub-study by the COVAD group. International journal of rheumatic diseases, v. 27, n. 5, 2024Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/76834. Acesso em: 15 mar. 2026. -
APA
Shumnalieva, R., Ravichandran, N., Hannah, J., Javaid, M., Darooka, N., Roy, D., et al. (2024). Characteristics of emerging new autoimmune diseases after COVID-19 vaccination: a sub-study by the COVAD group. International journal of rheumatic diseases, 27( 5). doi:10.1111/1756-185X.15178 -
NLM
Shumnalieva R, Ravichandran N, Hannah J, Javaid M, Darooka N, Roy D, Gonzalez DE, Velikova T, Milchert M, Shinjo SK. Characteristics of emerging new autoimmune diseases after COVID-19 vaccination: a sub-study by the COVAD group [Internet]. International journal of rheumatic diseases. 2024 ; 27( 5):[citado 2026 mar. 15 ] Available from: https://observatorio.fm.usp.br/handle/OPI/76834 -
Vancouver
Shumnalieva R, Ravichandran N, Hannah J, Javaid M, Darooka N, Roy D, Gonzalez DE, Velikova T, Milchert M, Shinjo SK. Characteristics of emerging new autoimmune diseases after COVID-19 vaccination: a sub-study by the COVAD group [Internet]. International journal of rheumatic diseases. 2024 ; 27( 5):[citado 2026 mar. 15 ] Available from: https://observatorio.fm.usp.br/handle/OPI/76834 - High prevalence of necrotizing myofibers in adult dermatomyositis muscle biopsies
- Rituximab as a treatment for human immunodeficiency virus-associated nemaline myopathy: What does the literature have to tell us?
- Clinical manifestations, outcomes, and antibody profile of Brazilian adult patients with dermatomyositis: a single-center longitudinal study
- Long-term effects of early pulse methylprednisolone and intravenous immunoglobulin in patients with dermatomyositis and polymyositis
- Vaccine hesitancy decreases in rheumatic diseases, long-term concerns remain in myositis: a comparative analysis of the COVAD surveys
- Type 1 diabetes, COVID-19 vaccines and short-term safety: Subgroup analysis from the global COVAD study
- Cardiovascular manifestations in idiopathic inflammatory myopathies
- Flares after COVID-19 infection in patients with idiopathic inflammatory myopathies: results from the COVAD study
- Vaccine hesitancy in patients with autoimmune diseases. [Carta]: data from the coronavirus disease-2019 vaccination in autoimmune diseases study
- Different clinical phenotypes in anti-melanoma differentiation-associated protein 5-associated positive dermatomyositis
Informações sobre a disponibilidade de versões do artigo em acesso aberto coletadas automaticamente via oaDOI API (Unpaywall).
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
